Related Experiment Video
Updated: Mar 28, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
Progress on Potential Therapeutic Targets for Sepsis-Related Cardiac Dysfunction: From Basic Research to Clinical
Yan Gao1, Rui Dai1, Chang Kong1
1Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
None:
Sepsis-related cardiac dysfunction (SRCD) is a severe complication of sepsis with complex pathophysiology involving dysregulated inflammatory responses, immune cell dysfunction, and multiple forms of programmed cell death. The review addresses the core pathophysiological mechanisms of SRCD, the central role of immune cell crosstalk (particularly between macrophages and neutrophils), and the evaluation of multi-target therapeutic strategies with an emphasis on natural compounds. We highlight promising interventions, including ginsenosides and melatonin, which exert multi-target protective effects. Future research should integrate insights across these themes to accelerate the development of precise therapies and improve patient survival and quality of life.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis III: Medical Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

